Completed NA INTERVENTIONAL 3-arm NCT04252534

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma (rEMS)

Management of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich Plasma

Sponsor: Ankara Universitesi Teknokent

Interventions PRP PRP combined Magnovision

Updated 4 times since 2020 Last updated: Feb 1, 2020 Started: Jan 1, 2017 Primary completion: Dec 30, 2019 Completion: Dec 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Retinitis Pigmentosa, this trial is completed. The trial is conducted by Ankara Universitesi Teknokent and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara Universitesi Teknokent

Data source: Ankara Universitesi Teknokent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.